Journal of Translational Medicine (Nov 2012)

The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods

  • Uceda Julia,
  • Carmona Loreto,
  • Muñoz Alejandro,
  • Marenco Jose L

DOI
https://doi.org/10.1186/1479-5876-10-S3-P28
Journal volume & issue
Vol. 10, no. Suppl 3
p. P28

Abstract

Read online

No abstracts available.